Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis NOVA

Max Ratio

26.86

Dividend Yield

3.52 %

5Y Dividend Growth

133.00 %

Consecutive Years

6 years

5Y Average Payout Ratio

53.32 %

Dividend History NOVA

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 3.52 %
Consecutive Years 6
Forward Annual Dividend 1.69 USD
Consistent Years 6
Dividend CAGR 3Y 29.91 %
Continuous Dividends
Dividend CAGR 5Y 22.25 %
Payout Ratio TTM 0.11 %
Dividend CAGR 10Y 16.38 %
Ex Dividend Date 09/18/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth NOVA

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin NOVA

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income NOVA

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM NOVA

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio NOVA

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Novo Nordisk A/S NOVA

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself NOVA

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 13.10
Forward PE 12.29
Enterprise Value Revenue 4.64
Price Sales TTM 0.67
Enterprise Value EBITDA 9.71
Price Book MRQ 8.16

Novo Nordisk A/S Dividends: 3.52 % Yield, History, Payment Schedule

NOVA
Current price
41.10 EUR +0.7 EUR (+1.73%)
Last closed 47.57 USD
ISIN US6701002056
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Frankfurt Exchange
Capitalization 211 376 324 608 USD
Yield for 12 month -55.90 %
1Y
3Y
5Y
10Y
15Y
NOVA
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+45 385 027 972 USD

Last Year

+36 298 426 606 USD

Current Quarter

+11 717 467 992 USD

Last Quarter

+12 011 436 159 USD

Current Year

+38 426 999 937 USD

Last Year

+30 708 968 076 USD

Current Quarter

+8 919 378 644 USD

Last Quarter

+10 003 825 806 USD
EBITDA 165 492 998 144 USD
Operating Margin TTM 44.35 %
Price to Earnings 13.10
Return On Assets TTM 21.11 %
PEG Ratio 1.64
Return On Equity TTM 71.47 %
Wall Street Target Price 53.26 USD
Revenue TTM 315 602 993 152 USD
Book Value 38.24 USD
Revenue Per Share TTM
Dividend Share 11.65 USD
Quarterly Revenue Growth YOY 5.10 %
Dividend Yield 3.52 %
Gross Profit TTM 263 334 002 688 USD
Earnings per share 3.63 USD
Diluted Eps TTM 3.63 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -26.50 %
Profit Margin 32.88 %

Technical Indicators NOVA

For 52 Weeks

43.08 USD 109.50 USD
50 Day MA 52.53 USD
Shares Short Prior Month 26 671 758
200 Day MA 63.45 USD
Short Ratio 1.66
Shares Short 27 691 852
Short Percent 0.82 %